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The turnover of phosphatidylinositol (PI) is believed to constitute a crucial step in the signaling pathways for stimulation 
of cells by a variety of bioactive substances, including differentiating a ents; however decisive vidence for the idea has 
not  been obtained. In the present paper, we investigated the involvement of PI turnover in cell differentiation using a 
human euroblastoma celline, LAN-1, which can be induced to differentiate along the neuronal pathway by both retino- 
ic acid (RA) and ~,-interferon (?-IFN). Analysis of labelled phosphatidylinositol metabolites from prelabelled cells indicat- 
ed a rapid decrease ofinositol 1,4,5-trisphosphate and 1,2-diacylglycerol within 1 min of induction of LAN-1 cell differen- 
tiation by RA, while no changes were observed in~,-IFN-treated cells. These findings indicate the occurrence of decreased 
inositol phospholipid turnover in RA-treated LAN-I cells and suggest that phosphoinositide-derived metaholites may 
not constitute g neral regulators ofcellular differentiation. 
Differentiation; Retinoic acid; Interferon-y; Phosphatidylinositol turnover 
1. INTRODUCTION 
It is well established that a very early response of 
cells to agonist stimulation is the rapid cleavage of 
polyphosphoinositides by phospholipase C [1-3]. 
The products of  this reaction, inositol 1,4,5-tris- 
phosphate (IP3) and 1,2-diacylglycerol (DG), are 
putative second messengers, with DG activating 
protein kinase C [4,5] and IP3 triggering release of 
Ca 2+ from intracellular stores [6,7]. It is also ac- 
cepted that the cellular levels of PI metabolites 
play key roles in the control of proliferation, 
transformation, and differentiation [8,9]. We 
decided to investigate the involvement of PI 
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turnover during differentiation of human 
neuroblastoma (NB) cells. The aim was to verify 
the hypothesis [9] that PI turnover is a general 
regulator of cell proliferation and differentiation, 
and that differentiation is induced by a decrease of 
PI turnover. Cultured mouse and human NB cells 
can be induced to differentiate by RA and 7-IFN 
[10-12]. Although recent studies [13,14] indicate 
that RA somehow affects genomic expression by 
its direct or indirect interaction with the cell 
nucleus, information is lacking with respect o the 
mechanism whereby the signal is transduced across 
the membrane. Furthermore, the mechanism by 
which IFN transmits its effects from the cell sur- 
face into the cell where its actions are manifested 
is still unclear [15,16]. 
2. MATERIALS AND METHODS 
2.1. Reagents 
[l(3)-3H]Glycerol (spec. act. 3 Ci/mmol) was from Amer- 
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sham (Bucks, England). all-trans-RA was from Sigma (St. 
Louis, MO). Human recombinant interferon-7 was from Gen- 
zyme Corp. (Boston, MA). The purchase of all other materials 
has been described [17]. 
2.2. Cell line 
Human neuroblastoma cell line LAN-1 was maintained in 
culture in RPMI 1640 medium containing 15% heat-inactivated 
FCS. Cells were grown, subcultured, and treated with RA and 
7-IFN as in [18]. 
2.3. Cell labelling procedure 
Inositol-depleted cells (2 x 106/point) were labelled for 24 h 
in inositol-free RPMI 1640 medium containing 10/~Ci/ml myo- 
[1,2-3H]inositol. Cells were then washed and 10 ml phenol red- 
free, inositol-free RPMI 1640 medium supplemented with 
35 mg/ml unlabelled myo-inositol were added. The incubation 
was continued at 37°C in the presence or absence of either 
10 -5 M RA or 1000 U/ml 7-IFN and terminated as above. 
DG levels were evaluated with the same protocol detailed 
above for inositol phosphates using [l(3)-3H]glycerol. 
2.4. Extraction procedures 
Lipids were extracted as described previously [17]. 
2.5. Separation of water-soluble inositol phosphates 
Anion-exchange high-performance liquid chromatography 
(HPLC) was used to separate [3H]inositol phosphates according 
to Dean and Moyer [19]. The column was calibrated using 
authentic labelled standards obtained commercially orprepared 
according to published methods [19,20]. 
2.6. Thin-layer chromatography of 1,2-diacylglycerol 
The pattern of distribution of the chloroform-soluble 
radioactivity into neutral ipids was determined by thin-layer 
chromatography (TLC). Lipid standards were visualized by ex- 
posure to iodine vapor. Spots corresponding to the location of 
authentic standards were scraped off and counted for radioac- 
tivity in a Packard Tri-Carb 4530 beta counter. 
3. RESULTS 
Levels o f  inosi to l  phosphates  in LAN-1  ceils 
were measured  over  the first 15 min  o f  t reatment  
wi th  RA.  Cel ls were label led to equ i l ib r ium with 
myo-[1,2-3Hlinositol to ensure that  any observed 
changes resulted f rom changes in mass and not  o f  
speci f ic  activit ies. Di rect  phosphory la t ion  o f  myo-  
inos i to l  was min imized  by add i t ion  o f  an approx .  
1000-fold excess o f  un labe l led  inos i to l  to the 
med ium used for  the second incubat ion .  A f te r  ad- 
d i t ion  o f  10 -5 M RA to cells, the level o f  [3H]IP3 
fell to  approx .  20°7o o f  the cont ro l  va lue wi th in  
1 min  (fig. 1C). Th is  level remained  35-50070 lower  
than  contro l  values,  up to 15 rain. In  contrast ,  the 
level o f  [3H]IP3 did not  change,  re lat ive to contro l ,  
up to 15 min  after  - / - IFN induct ion  o f  d i f ferent ia -  
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Fig.l. Effects of treatment with RA and 7-IFN on inositol 
phosphate l vels in LAN-I cells. LAN-1 cells were prelabelled 
with myo-[l,2-3H]inositol, washed, and incubated in medium 
supplemented with a 1000-fold excess of unlabelled myo- 
inositol in the absence (solid bar) or presence of either 10 -5 M 
RA (clear bar) or 1000 U/ml T-IFN (stippled bar). Cells were 
extracted and separation of inositol phosphates was performed 
by anion-exchange HPLC as described [26]. Data points are 
single determinations from a typical experiment reproduced 
three times. Maximum responses were 5894 (A), 4120 (B), 977 
(C) cpm/2 × 106 cells. 
286 
Volume 243, number 2 FEBS LETTERS January 1989 
tion (fig.lC). Measurements of [3H]inositol 
monophosphate (IP) and [3H]inositol bisphos- 
phate (IP2) gave results similar to those obtained 
for IP3, with lower relative response (fig. 1A,B) for 
RA-treated cells, while 7-IFN treatment did not 
alter the levels of IP and IP2 at any time point ex- 
amined (fig. 1A,B). Evaluation of very early points 
(15 and 30 s) gave the same pattern of results of 
1 rain treatments (not shown). 
It would be expected that a decline in IP3 would 
be accompanied by a decrease in DG levels. 
Therefore, we measured the DG levels in cells 
treated with RA and 7-IFN. Fig.2A shows that RA 
treatment of LAN-I cells decreased the levels of 
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Fig.2. Effects of treatment with RA and 7-IFN on the levels of 
DG (A) and TG (B). LAN-1 cells were prelabelled with 
[l(3)-3H]glycerol, washed and incubated in medium 
supplemented with a 1000-fold excess of unlabelled glycerol in 
the absence (solid bar) or presence ofeither 10 -5 M RA (clear 
bar) or 1000 U/ml y-IFN (stippled bar). Cells were extracted, 
and separation fneutral lipids was performed as described in 
section 2. Data points are single determinations from a typical 
experiment reproduced three times. Maximum responses were 
20044 (A) and 23013 (B) cpm/2 x 106 cells. 
DG to approx. 50°70 of control within 1 min of RA 
induction of differentiation. By 15 min, levels of 
DG were still 60070 of control values (fig.2A). In 
contrast, treatment of LAN-1 cells with 7-IFN did 
not change the levels of DG at any experimental 
point observed (fig.2A). Finally, to ascertain that 
the decrease in DG levels was not simply an artifact 
of RA, we measured triacylglycerol (TG) levels. 
Fig.2B shows that no differences were observed 
between control and RA- or 7-IFN-treated cultures 
in the incorporation of [3H]glycerol into TG. 
4. DISCUSSION 
The present results demonstrate hat in vitro in- 
duction of differentiation of LAN-1 neuroblasto- 
ma cells by RA is associated with a rapid decrease 
of PI turnover, while y-IFN treatment does not 
alter the levels of the inositol phospholipid-derived 
metabolites (i.e. IP3 and DG). 
The available evidence suggests that RA, an 
analog of vitamin A, has multiple effects on cells. 
It may constitute a natural morphogen in the 
developing chick limb bud [22]. In neuroblastoma 
tissue cultures, RA appears to be a potent com- 
pound for promoting differentiation, inhibiting 
cell growth, and perhaps reducing tumorigenicity 
[11,18,23,24]. Although the exact molecular 
mechanisms causing effects of RA on cellular dif- 
ferentiation remain to be elucidated, recent studies 
indicate that RA somehow affects genomic expres- 
sion by its direct or indirect interaction with the 
cell nucleus [13,14,25]. One possibility could be 
that the primary site of action of RA is located on 
the plasma membrane. Through such interaction, 
'second messengers' are formed which in turn 
make possible the interaction between RA and 
specific nuclear RA receptor(s), later affecting 
gene expression. Based on the hypothesis that the 
cellular levels of certain PI metabolites play key 
roles in the control of proliferation, transforma- 
tion, and differentiation [3,9], we decided to test 
the generality of this phenomenon by studying the 
early events in neuroblastoma cell differentiation. 
Furthermore, we decided to compare the effects 
of RA with those of 7-IFN, a naturally occurring 
differentiating agent [26], with the aim of confirm- 
ing the previous hypothesis [9]. Interferon is an- 
tiviral, has immunoregulatory effects in living 
cells, and inhibits cell growth [27]. IFNs have been 
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shown to have a direct effect on the multiplication 
of various human tumour cells [28]. However, lit- 
tle is known about the mechanism by which IFN 
transmits its effects from the cell surface into the 
cell. Mills et al. [15] reported that IFNs do not 
signal cells by rapid alterations in phosphoino- 
sitide-metabolite l vels, which apparently is con- 
tradictory to the findings of Yap et al. [16], where 
very rapid and transient IP3 and DG increases are 
early events in the interferon-induced transmem- 
brane signaling process. Our findings seem to con- 
firm the data of Mills et al. and demonstrate that 
in vitro induction of neuronal differentiation by 
RA is associated with a rapid decrease of PI turn- 
over. Decreases in inositol 1,4,5-trisphosphate 
and diacylglycerol were detectable within 1 min 
after the addition of the inducing agent RA. These 
decreases constitute the earliest reported events in 
neuroblastoma differentiation. Since no difference 
was observed in the pattern of inositol phosphates 
between RA-treated washed cells and RA-treated 
unwashed cells, and no radioactivity co-migrating 
with inositol phosphates was observed in the super- 
natant derived from washed cells, the possibility of 
a detergent-like effect of RA is unlikely (not 
shown). The possibility that the very early 
decreases in concentration of PI metabolites after 
induction by RA of LAN-1 cell differentiation 
were due to a decrease in inositol or glycerol up- 
take was eliminated, as no decrease was observed 
in either myo-[1,2-3H]inositol or [l(3))H]glycerol 
uptake in RA-treated cultures, compared to con- 
trol cells (not shown). Thus, the observed changes 
in PI metabolites reflect real changes in mass 
rather than in specific activity. 
These data suggest hat the metabolites derived 
from inositol phospholipid turnover may be part 
of the mechanism by which certain RA signals are 
transduced, further indicating that PI turnover 
may not constitute a general regulator of cellular 
differentiation. 
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